longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Heamonetics

HAE

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 51.22, above the reasonable range, cheaper than 19.56% of the time in the past 5 years, and the industry ranks 16/45, the industry Median -0.42.

51.22xP/E
$108.40Stock price
$2.12Earnings per share
51.22xP/E
Stock price$108.40Earnings per share$2.12

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
34.69x
Typical range
23.08x–50.88x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
015304560

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
MDLNUSMedline
59.29x45.87%$41.57B
HAEUSHeamonetics
51.22x93.33%$4.93B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.